SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-Jul-24 6:04 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 05-Jul-24 | Option Exercise | 15,000 | $19.73 | $295,950.00 | 51% 29.26K to 44.26K | |
09-Jul-24 6:04 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 05-Jul-24 | Planned Option Sale | 15,000 | $44.08 | $661,200.00 | (34%) 44.26K to 29.26K | |
24-Jun-24 5:08 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 21-Jun-24 | Option Exercise | 15,000 | $19.73 | $295,950.00 | 51% 29.26K to 44.26K | |
24-Jun-24 5:08 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 21-Jun-24 | Planned Option Sale | 15,000 | $44.66 | $669,900.00 | (34%) 44.26K to 29.26K | |
20-Mar-24 6:34 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 1,741 | $38.14 | $66,401.70 | (6%) 31.0K to 29.26K | |
03-Mar-23 4:47 PM View: | Crinetics Pharmaceuticals, ... (CRNX) | 01-Mar-23 | Grant | 14,000 | -- | -- | 100% 0 to 14.0K | |
24-Jun-21 6:44 PM View: | Arrowhead Research Corp. (ARWR) | 22-Jun-21 | Market Sale | 3,625 | $89.22 | $323,422.00 | (3%) 109.38K to 105.75K | < 1% |
08-Jan-21 6:05 PM View: | Arrowhead Research Corp. (ARWR) | 07-Jan-21 | Market Sale (Planned) | 15,625 | $75.00 | $1,171,880.00 | (12%) 125.0K to 109.38K | (6%) |